4basebio PLC (LON:4BB) Insider Acquires £12,891.20 in Stock

4basebio PLC (LON:4BB) insider Amy Walker purchased 1,151 shares of 4basebio stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of GBX 1,120 ($14.44) per share, with a total value of £12,891.20 ($16,616.65).

4basebio Stock Up 0.4 %

4basebio stock opened at GBX 1,120 ($14.44) on Thursday. 4basebio PLC has a twelve month low of GBX 832.50 ($10.73) and a twelve month high of GBX 1,820 ($23.46). The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The firm has a market cap of £143.47 million, a PE ratio of -1,435.90 and a beta of 1.09. The firm’s 50 day moving average price is GBX 1,175.06 and its two-hundred day moving average price is GBX 1,276.57.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.